25 May 2013
Keywords: round-up, products, entering, clinical, trials, protein, design
Article | 27 January 1998
Protein Design Labs has started a Phase I trial of a SMART (humanized)anti-CD3 monoclonal antibody, which may have a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.